What is the recommended birth control for an adolescent female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Birth Control for a 14-Year-Old Female

Low-dose combined oral contraceptives (COCs) containing 30-35 μg of ethinyl estradiol with a progestin such as levonorgestrel or norgestimate are the recommended first-line birth control option for adolescent females. 1

First-Line Options

  • COCs are the most popular method of hormonal contraception among adolescents, offering reliable effectiveness with a perfect-use failure rate of 0.3% (though typical use failure rate is 9%) 1, 2
  • Low-dose COCs (containing 35 μg ethinyl estradiol or less) are appropriate first-line options for adolescents, balancing effectiveness with minimal side effects 1
  • No pelvic examination is required before initiating COCs, removing a potential barrier to contraception access for adolescents 1
  • COCs can be started on the same day as the visit ("quick start"), making them immediately accessible 1

Benefits and Considerations of COCs

  • COCs provide additional non-contraceptive benefits including decreased menstrual cramping and blood loss, which can be particularly helpful for adolescents with heavy menstrual cycles 3
  • Common transient side effects include irregular bleeding, headache, and nausea, which typically resolve after the first few months of use 1
  • COCs have few contraindications in healthy adolescents but should not be prescribed for patients with severe hypertension, liver dysfunction, migraines with aura, or history of thromboembolism 1
  • The most serious adverse event is increased risk of blood clots (3-4 per 10,000 woman-years compared to 1 per 10,000 in non-users), though this risk is still lower than during pregnancy 1

Alternative Options

  • The levonorgestrel intrauterine device (IUD) is highly effective and provides excellent menstrual suppression, making it suitable for adolescents with heavy menstrual bleeding 3
  • Depot medroxyprogesterone acetate (DMPA) injections offer convenience with dosing every 13 weeks but may cause bone mineral density reductions and weight gain in some users 1
  • Progestin-only pills are valuable for adolescents who cannot use estrogen-containing methods, though they require very stringent adherence 1, 4

Practical Implementation

  • When prescribing COCs, start with a monophasic pill containing 30-35 μg of ethinyl estradiol and levonorgestrel or norgestimate 1, 5
  • Schedule a follow-up visit 1-3 months after initiating COCs to address any adverse effects or adherence issues 1
  • Counsel patients that backup contraception (condoms or abstinence) should be used for the first 7 days after starting COCs 1
  • Emphasize the importance of consistent condom use for STI protection regardless of hormonal contraceptive method 1

Important Counseling Points

  • Discuss strategies to promote adherence, such as cell phone alarms or support from a trusted adult 1
  • Provide clear instructions on what to do if pills are missed 1
  • Recommend daily intake of 1300 mg of calcium and 600 IU of vitamin D for skeletal health, particularly important if considering DMPA 1, 3
  • Consider prescribing emergency contraception in advance as part of routine adolescent care 1

Pitfalls to Avoid

  • Don't require a pelvic examination before prescribing hormonal contraception, as this creates an unnecessary barrier to access 1
  • Don't withhold contraception due to concerns about smoking in adolescents under 35 years old, as smoking is not a contraindication to COC use in this age group 1
  • Don't assume that all antibiotics reduce COC effectiveness; only rifampin has been shown to significantly impact contraceptive efficacy 1, 6
  • Don't switch between brand-name and generic low-dose COCs without consideration, as differences in bioavailability may affect contraceptive efficacy and increase breakthrough bleeding 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Birth Control Options for Teens with Heavy Menstrual Cycles

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.